Bone Biologics (BBLGW) Capital Expenditures (2015)

Bone Biologics (BBLGW) has reported Capital Expenditures for 1 consecutive years, with $504.0 the latest figure, recorded in Q1 2015.

• On a quarterly basis, Capital Expenditures changed N/A year-over-year to $504.0 in Q1 2015; TTM through Dec 2015 was $504.0, a N/A change from a year earlier, with the FY2015 full-year figure at $504.0, down 95.77% from the prior year.
• Capital Expenditures was $504.0 for Q1 2015 at Bone Biologics.
• Over five years, Capital Expenditures peaked at $504.0 in Q1 2015 and troughed at $504.0 in Q1 2015.